Prevnar

Description

Prevnar® (Pneumococcal 7-valent Conjugate Vaccine)

Prevnar®, is a conjugate vaccine containing capsular antigens of Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F individually conjugated to diphtheria CRM197 protein.

Prevnar® is indicated for active immunization of infants and toddlers against invasive disease caused by S. pneumoniae due to capsular serotypes included in the vaccine (4, 6B, 9V, 14, 18C, 19F, and 23F). It is also indicated for active immunization of infants and toddlers against otitis media caused by serotypes included in the vaccine

Immunisation Guideline

The routine schedule followed for the vaccine is three primary doses at  2, 4 and 6 months of age and a booster at 12-15 months of age.

Additional information

vaccine-type

Pneumococcal conjugate vaccine, 7 valent (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F)

manufacturer

Pfizer

country-of-manufacture

USA

pharmaceutical-form

Liquid

package-size

1 Dose

route-of-administration

Intramuscular

preservative

None

Contraindications

Hypersensitivity to any component of the vaccine, including diphtheria toxoid, is a contraindication to use of this vaccine.